Daptomycin vs. glycopeptides in the treatment of febrile neutropenia: results of the Izmir matched cohort study

ConclusionsThese findings suggest that although not better, daptomycin efficacy is comparable to vancomycin if used as empiric therapy in the treatment of adult febrile neutropenia. We conclude that daptomycin may be used at least as a salvage therapy alternative to glycopeptides in the treatment of adult febrile neutropenia cases. A large, randomized-controlled trial may further consolidate the evidence related to this question.

Source: Infection - March 28, 2019 Category: Infectious Diseases Source Type: research